High persistence of biologic therapy in patients with Psoriatic arthritis: a real-world evidence from a high-complexity hospital in Colombia.

ABSTRACT:

Introduction

Psoriatic arthritis (PsA) is a chronic inflammatory disease that significantly impacts patients' quality of life, underscoring the importance of timely diagnosis and appropriate treatment. In Colombia, the estimated prevalence is 13.5 cases per100,000 inhabitants; however, few studies have addressed this condition in the local context. Although there is no single international consensus on treatment, various clinical guidelines agree on the effectiveness of biologic therapies. Despite this, data on Colombian patients treated with biologic agents remain scarce. Therefore, this study aims to describe the clinical and paraclinical characteristics, as well as the outcomes, of patients with PsA receiving biologic treatments-representing the first such analysis conducted in

SUBMITTER: Hormaza-Jaramillo A 

PROVIDER: S-EPMC12426402 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature